Monopar Therapeutics SC 13G / ASTRAZENECA ownership change | MNPR 28 Oct 24

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

	AstraZeneca PLC

Dated: October 28, 2024	By:	/s/ Adrian Kemp
		Adrian Kemp
		Company Secretary

	Alexion Pharmaceuticals, Inc.

Dated: October 28, 2024	By:	/s/ Todd Spalding
		Todd Spalding
		Secretary

Monopar Therapeutics (MNPR) SC 13GMonopar Therapeutics / ASTRAZENECA ownership change